Skip to main content
SpringerLink
Log in

Fortgeschrittenes und metastasiertes Melanom

Hohe 5-Jahres-Überlebensraten nach Immuncheckpointblockade

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Larkin J et al. N Engl J Med. 2015;373(1):23-34

  2. Hodi FS et al. Lancet Oncol. 2018;19(11):1480-92

  3. Robert C et al. N Engl J Med. 2015;372(26):2521-32

  4. Schachter J et al. Lancet. 2017;390(10105):1853-62

  5. Larkin J et al. N Engl J Med. 2019;381(16):1535-46

  6. Robert C et al. Lancet Oncol. 2019;20(9):1239-51

  7. Robert C et al. N Engl J Med. 2019;381(7):626-36

Download references

Author information

Authors and Affiliations

  1. FA für Onkologie, Lena-Christ-Str. 17, 82152, Planegg, Germany

    Andreas Schalhorn

Authors
  1. Andreas Schalhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Schalhorn.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schalhorn, A. Hohe 5-Jahres-Überlebensraten nach Immuncheckpointblockade. InFo Hämatol Onkol 23, 29–30 (2020). https://doi.org/10.1007/s15004-020-7977-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-020-7977-8

Search

Navigation